Diabetes Care Devices – Market Insights – United States
The US diabetes care device market has shown strong recovery from the short-term negative impacts of the COVID-19 pandemic and will resume prepandemic growth trends in the coming years. Market growth will be driven by the introduction of new technologies and innovative products, such as hybrid closed-loop insulin pumps and patch pumps. These advanced products are anticipated to command higher prices and contribute to strong market growth over the forecast period. In particular, the CGM device segment will see rapid growth over the forecast period, supported by recent CMS updates to Medicare coverage that have relaxed the criteria for beneficiaries to qualify for CGM reimbursement, improving patient access to these devices.
This Medtech 360 Report provides comprehensive data and analysis on the state of the diabetes care device market in the US from 2019 through 2032.
The US diabetes care device market will grow strongly through 2032.
How will growth vary between product segments?
What are the factors driving market expansion?
CMS has recently expanded Medicare coverage for CGM devices.
How will this expanded coverage impact the CGM device segment over the forecast period?
Which competitors are going to benefit the most from the recent changes in CMS policy?
GLP-1 receptor agonists have been seeing growing adoption among the US patient population in recent years.
How will adoption of GLP-1 receptor agonists affect the US diabetes care device market?
Which market segments will be more impacted by the growing popularity of GLP-1 receptor agonists?
Numerous new competitors are expected to enter this space within the forecast period.
Who are these competitors and what products are they bringing to the market?
Which segments are seeing the most incoming competitors?
The insulin delivery device market is large and will continue to expand rapidly.
What are new innovations are emerging in this segment?
What factors are driving growth in this market?
Which types of devices are seeing the strongest adoption, and how are these trends affecting other product segments?
Table of contents
- Diabetes Care Devices - Market Insights - United States
- COVID-19 Methodology
- Abstract
- Executive Summary
- Key Report Updates
- Diabetes Care Device Market
- Glucose Monitoring Device Market
- Insulin Delivery Device Market
- Appendix
Suchitra Ghoshal is an associate healthcare research & data analyst within the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at Clarivate, specializing in the biosurgical agent market. Suchitra holds a Bachelor’s degree in Life Sciences from Delhi University, and a Master’s degree in Environmental Science from Guru Gobind Singh Indraprastha University, New Delhi.